Phenotypic variability in 17β-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls
10.1111/j.1365-2265.2007.02829.x
Saved in:
Main Authors: | Hughes, I.A., Lee, Y.S., Harland, S., Kirk, J.M.W., Stanhope, R.G., Johnston, D.I., Auchus, R.J., Andersson, S. |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/25667 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Probing the origins of 17β-hydroxysteroid dehydrogenase type 1 inhibitory activity via QSAR and molecular docking
by: Kakanand Srungboonmee, et al.
Published: (2018) -
Increased estrogen sulfatase (STS) and 17βhydroxysteroid dehydrogenase type l(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients
by: Niramol Chanplakorn, et al.
Published: (2018) -
Expression of 3β-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro
by: Gunasegaram, R., et al.
Published: (2013) -
Genetic variation of 3β-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk
by: Devgan, S.A., et al.
Published: (2012) -
Genetic variation of 3β-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk
by: Devgan, S.A., et al.
Published: (2016)